New markers of inflammation and endothelial cell activation: Part I

PE Szmitko, CH Wang, RD Weisel, JR de Almeida… - Circulation, 2003 - Am Heart Assoc
and by CD40/CD40 ligand (CD40L and CD154) interactions. 18–22 Once adherent, the
monocytes transmigrate into the tunica intima, the innermost layer of the arterial wall …

Endothelial function testing as a biomarker of vascular disease

S Verma, MR Buchanan, TJ Anderson - Circulation, 2003 - Am Heart Assoc
2054 vessels, Ach evokes a NO-mediated vasodilatory response; however, in patients with
endothelial dysfunction, this effect is blunted or paradoxical vasoconstriction may occur. 5 …

Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction

S Verma, SH Li, CH Wang, PWM Fedak, RK Li… - Circulation, 2003 - Am Heart Assoc
Background—Adipocyte-derived hormones may represent a mechanism linking insulin
resistance to cardiovascular disease. In the present study, we evaluated the direct effects of …

Biomarkers of vascular disease linking inflammation to endothelial activation: Part II

PE Szmitko, CH Wang, RD Weisel, GA Jeffries… - Circulation, 2003 - Am Heart Assoc
and modulation of matrix metalloproteinase (MMP) activity, toward conditions favoring
compromise of the fibrous cap. 27–29 On plaque rupture, activated platelets may interact …

Endothelial progenitor cells: new hope for a broken heart

PE Szmitko, PWM Fedak, RD Weisel, DJ Stewart… - Circulation, 2003 - Am Heart Assoc
The mobilization and incorporation of BM-derived EPCs has recently been shown to
modulate reendothelialization at sites of endothelial cell damage. 18, 19 Both studies …

C-reactive protein and atherothrombosis—beyond a biomarker: an actual partaker of lesion formation

S Verma, ETH Yeh - American Journal of Physiology …, 2003 - journals.physiology.org
ATHEROSCLEROSIS AND ITS COMPLICATIONS represent the most common cause of
death in Western societies. Over the past few years we have witnessed a paradigm shift in …

The endothelium in health and disease-a target for therapeutic intervention

CR Triggle, M Hollenberg, TJ Anderson… - Journal of Smooth …, 2003 - jstage.jst.go.jp
In this review we discuss the contribution of NO, prostacyclin and endotheliumderived
relaxing factor—endothelium-derived hyperpolarizing factor, or EDHF, to vascular function …

Endothelial dysfunction and the metabolic syndrome

GE McVeigh, JN Cohn - Current diabetes reports, 2003 - Springer
The metabolic syndrome is a highly prevalent multifaceted clinical entity produced through
the interaction of genetic, hormonal, and lifestyle factors. A distinctive constellation of …

Left ventricular hypertrophy and endothelial dysfunction in chronic hemodialysis patients

A Yildiz, H Oflaz, H Pusuroglu, F Mercanoglu… - American journal of …, 2003 - Elsevier
Background: Endothelial dysfunction (ED), which is a risk factor for atherosclerosis, has
been reported recently in chronic hemodialysis (CHD) patients. In this study, we aim to …

p38 MAPK inhibitors ameliorate target organ damage in hypertension: Part 1. p38 MAPK-dependent endothelial dysfunction and hypertension

H Ju, DJ Behm, S Nerurkar, ME Eybye… - … of Pharmacology and …, 2003 - ASPET
Numerous mediators, believed to play a role in endothelial dysfunction (eg, neurohormones,
cytokines, hypoxia, and stretch), have been shown to activate p38 mitogen-activated protein …